Keyphrases
Cholangiocarcinoma
100%
Sorafenib
40%
Epigenome
35%
Dysregulation
25%
Intrahepatic Cholangiocarcinoma (iCCA)
24%
Pan-cancer Analysis
23%
Hepatocellular Carcinoma
20%
Gene Therapy
20%
SOX17
20%
Current Therapies
20%
Tumor Selectivity
20%
Tumor Suppressor
20%
Epigenetic Events
20%
Organic Cation Transporter 1
20%
Organic Cation Transporter
20%
Transforming Growth Factor-β
20%
γ-secretase Inhibitor
20%
Molecular Pathogenesis
20%
Genetic Modification
20%
Cholangiocytes
16%
Tumor
15%
Epigenomics
15%
Immunology and Microbiology
Drug Resistance
42%
Epigenetics
40%
Sorafenib
40%
Cholangiocyte
40%
Transcriptome
22%
Histone
22%
DNA Methylation
22%
Post-Translational Modification
20%
Energy Metabolism
20%
Evolution
20%
Cholangiocarcinoma Cell Line
20%
Genomic Instability
20%
Mortality Rate
20%
Chromatin Assembly and Disassembly
20%
Sensitization
20%
Morphology
20%
Hepatobiliary System
20%
Notch
20%
Immune Cell Infiltration
20%
Hepatitis
20%
Medicine and Dentistry
Cholangiocarcinoma
100%
Neoplasm
51%
Cancer
27%
Malignant Neoplasm
23%
Gene Mutation
20%
Cancer Growth Factor
20%
Molecular Pathology
20%
Mediator
20%
Sensitization
20%
Notch
20%
Gene Therapy
20%
Sorafenib
20%
